Covered recipient · General Payments record
RAVIN V PATEL
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$856.27
- Reported across 27 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $589.65 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $223.59 | 10 |
| ABBVIE INC. | $150.00 | 1 |
| INTRA-SANA LABORATORIES | $97.10 | 3 |
| Exact Sciences Corporation | $52.70 | 2 |
| Acerta Pharma LLC | $44.52 | 2 |
| PFIZER INC. | $21.74 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $150.00 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105199884 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.99 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105832567 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.53 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104468632 | CMS |
| Exact Sciences Corporation | $31.24 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114563391 | CMS |
| Exact Sciences Corporation | $21.46 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114563395 | CMS |
| Intra-Sana Laboratories | $50.00 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138619430 | CMS |
| Intra-Sana Laboratories | $24.36 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138619432 | CMS |
| Intra-Sana Laboratories | $22.74 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138619434 | CMS |
| Lilly USA, LLC | $26.97 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135355306 | CMS |
| Lilly USA, LLC | $23.44 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135332242 | CMS |
| Lilly USA, LLC | $20.04 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135329818 | CMS |
| Lilly USA, LLC | $25.95 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135329822 | CMS |
| Lilly USA, LLC | $20.82 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135362110 | CMS |
| Lilly USA, LLC | $20.86 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135360770 | CMS |
| Lilly USA, LLC | $22.54 | 08/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135380867 | CMS |
| Lilly USA, LLC | $17.16 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135362112 | CMS |
| Lilly USA, LLC | $22.46 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135360772 | CMS |
| Lilly USA, LLC | $23.35 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135355304 | CMS |
| PFIZER INC. | $21.74 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132006508 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.